JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (5): 49-55.doi: 10.6040/j.issn.1671-7554.0.2017.125

Previous Articles     Next Articles

Correlation between TWEAK and cardiac remodeling in essential hypertensive patients

LI Rui1, MA Weihong1, REN Manyi2, ZHAO Mengmeng1, JIANG Shan1, JU Yuanyuan1, GUO Ying1, SUN Zhaohui1, SUI Shujian1   

  1. 1. Department of Cardiology, Second Hospital of Shandong University, Jinan 250033, Shandong, China;
    2. Department of Cardiology, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China
  • Received:2017-02-09 Online:2017-05-10 Published:2017-05-10

PDF (PC)

159

Abstract: Objective To investigate the association between tumor necrosis factor-like weak inducer of apoptosis(TWEAK)and cardiac remodeling in essential hypertensive patients. Methods A total of 88 hypertensive patients enrolled as the hypertension group were divided into two subgroups according to the serum level of soluble TWEAK(sTWEAK): high sTWEAK group(n=51)and low sTWEAK group(n=37). Another 20 healthy subjects served as the control group. The mRNA expression of TWEAK in peripheral blood mononuclear cells(PBMCs)was detected using real-time PCR(RT-PCR). sTWEAK and matrix metalloproteinase 1(sMMP-1)were measured with enzyme linked immunosorbent assay(ELISA). The left atrium diameter(LAD), left atrial volume(LAV), left atrial volume index(LAVI), early wave of mitral flow(E), atrial wave of mitral flow(A), ratio of mitral flow early wave to atrial wave(E/A), and ratio of mitral flow early wave to mitral annular early diastolic velocity(E/E')of mitral valve ring were measured with echocardiography. Results The levels of sTWEAK, TWEAK mRNA and sMMP-1 were higher in 山 东 大 学 学 报 (医 学 版)55卷5期 -李睿,等.TWEAK与原发性高血压患者心脏重塑的相关性 \=-the hypertension group than in the control group(P<0.05), These indexes were significantly greater in the high sTWEAK group than in the low sTWEAK group(P<0.01). LAVI and E/E' were greater in the hypertension group than in the control group(P<0.05), and were significantly greater in the high sTWEAK group than in the low sTWEAK group(P<0.01). Furthermore, the sTWEAK and TWEAK mRNA showed a significant positive correlation with sMMP-1, LAVI and E/E'(P<0.01). Conclusion Cardiac remodeling in essential hypertensive patients might be correlated with up-regulated TWEAK.

Key words: Essential hypertension, Tumor necrosis factor-like weak inducer of apoptosis, Matrix metalloproteinase 1, cardiac remodeling

CLC Number: 

  • R542.2
[1] Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting[J]. Nature reviews Drug discovery, 2008, 7(5): 411-425.
[2] Wiley SR, Cassiano L, Lofton T, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis[J]. Immunity, 2001, 5(5): 837-846.
[3] Burkly LC, Michaelson JS, Hahm K, et al. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease[J]. Cytokine, 2007, 40(1): 1-16.
[4] Chorianopoulos E, Jarr K, Steen H, et al. Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome[J]. Clin Res Cardiol, 2010, 211(1): 322-326.
[5] Jarr KU, Eschricht S, Burkly LC, et al. TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in mice[J]. Mediators inflamm, 2014, 2014: 131950. doi:10.1155/2011/131950.
[6] Richter B, Rychli K, Hohensinner PJ, et al. Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis(TWEAK)in advanced ischemic and non-ischemic heart failure[J]. Atherosclerosis, 2010, 213(2): 545-548.
[7] Karadurmus N, Tapan S, Cakar M, et al. Lower plasma soluble TWEAK concentration in patients with newly diagnosed hypertension[J]. Clin Invest Med, 2012, 35(1): 20-26.
[8] 徐忠阳, 王立启, 徐振兴, 等. RhoA/ROCK信号通路与原发性高血压患者血压变异性及颈动脉内膜中层厚度的相关性[J]. 山东大学学报(医学版), 2015, 53(2): 48-51. XU Zhongyang, WANG Liqi, XU Zhenxing, et al. Correlations among RhoA/ROCK signaling pathway, blood pressure variability and carotid artery intima-media thickness in essential hypertensive patients[J]. Journal of Shandong University(Health Science), 2015, 53(2): 48-51.
[9] Bergman MR, Kao RH, McCune SA, et al. Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats[J]. Am J Physiol, 1999, 277(2 Pt 2): 543-550.
[10] Nagueh SF, Stetson SJ, Lakkis NM, et al. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy[J]. Circulation, 2001, 103(14): 1844-1850.
[11] Novoyatleva T, Janssen W, Wietelmann A, et al. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy[J]. Cytokine, 2013, 64(1): 43-45.
[12] Mustonen E, Ruskoaho H, Rysa J. Thrombospondin-4,tumour necrosis factor like weak inducer of apoptosis(TWEAK)and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling[J]. AnnMed, 2012, 44(8): 793-804.
[13] Chen HN, Wang DJ, Ren MY, et al. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-small ka, CyrillicB pathway[J]. Mol Biol Rep, 2012, 39(8): 8231-8241.
[14] 王其磊, 任满意, 王德金, 等. TWEAK通过P38MAPK途径促进大鼠心肌成纤维细胞Ⅰ型胶原和MMP-1的表达[J]. 山东大学学报(医学版), 2012, 50(11): 43-47. WANG Qilei, REN Manyi, WANG Dejin, et al. TWEAK promotes expressions of collagen Ⅰ and matrix metalloproteinase-1 in rat cardiac fibroblasts via P38MAPK pathway[J]. Journal of Shandong University(Health Science), 2012, 50(11): 43-47.
[15] 巨媛媛, 任满意, 李睿, 等. TWEAK通过ERK1/2通路促进大鼠心肌成纤维细胞MMP2与Ⅰ型胶原表达[J]. 山东大学学报(医学版), 2016, 54(5): 23-28. JU Yuanyuan, REN Manyi, LI Rui, et al. Tumor necrosis factor-like weak inducer of apoptosis promotes expression of matrix metalloproteinase 2 and collagen Ⅰ in rat cardiac fibroblasts via the ERK1/2 signaling pathway[J]. Journal of Shandong University(Health Science), 2016, 54(5): 23-28.
[16] Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases[J]. Bull NYU Hosp Jt Dis, 2006, 64(1-2): 20-24.
[17] Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease[J]. J Clin Invest, 2007, 117(3): 568-575.
[18] Martos R, Baugh J, Ledwidge M, et al. Evidence of increased myocardial collagen turnover linked to diastolic dysfunction[J]. Circulation, 2007, 115(7): 888-895.
[19] 钱志勇, 张赛丹, 钟小芹, 等. 左心房容积指数与高血压患者左心室舒张功能相关性探讨[J]. 中国现代医学杂志, 2011, 21(29): 3631-3634. QIAN Zhiyong, ZHANG Saidan, ZHONG Xiaoqin, et al. Evaluation relationship between left atrial volume index and left ventricular diastolic function in patients with hypertension[J]. China Jounal of Modern Medicine, 2011, 21(29): 3631-3634.
[20] Pachel C, Mathes D, Bayer B, et al. Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation[J]. PLoS One, 2013, 8(11): 78938.
[21] Peng QL, Shu XM, Tian XL, et al. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis[J]. Arthritis Res Ther, 2014, 16(1): 26.
[22] Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses[J]. Immunological reviews, 2011, 244(1): 99-114.
[23] Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med, 2002, 347(20): 1557-1565.
[24] Wajant H. The TWEAK-Fn14 system as a potential drug target[J]. Br J Pharmacol, 2013, 170(4): 748-764.
[1] JU Yuanyuan, REN Manyi, LI Rui, ZHAO Mengmeng, SUI Shujian. Tumor necrosis factor-like weak inducer of apoptosis promotes expression of matrix metalloproteinase 2 and collagen Ⅰ in rat cardiac fibroblasts via the ERK1/2 signaling pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 23-28.
[2] MA Xiao1， WANG Yue-ming2， LI Hong-shi3, KAN Xiao-hong4，ZHAO Jing4, YUE Xin4, ZHANG Yun4, ZHONG Ming4, LI Li4. Evaluation of efficacy and safety of manidipine hydrochloride among patients with mild or moderate essential hypertension: a multicenter， randomized， doubleblind study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(8): 58-61.
[3] ZHAO Li-xiang， WU Xin-ning， WANG Xi， LI Na， CHEN Tong-shuai, LIU Jun-ni， BU Pei-li. Effects of NAD on the mRNA expression of collagen  type I induced by Angiotensin II in cardiac fibroblasts [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 1-5.
[4] QI Jia1, MA Yu-ru2, YANG Yong-li3, LI Li1, MA Xiao4. Analysis of linear and nonlinear heart rate variability in patients with essential hypertension and ventricular premature beats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 68-71.
[5] XIA Long1, MIAO Wei2, WANG Li-qi2, ZHU Shi-ming2. Research of plasma Apelin level in hypertensive patients with heart failure [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 75-.
[6] LI Qian, SUN Shuzhen, WANG Yi, LI Yan, CHEN Yao, NIU Na. Effects of diet-control, aerobic training and rosiglitazone on cardiac interstitial remodeling in high fatfed obese rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(5): 14-.
[7] HUANG Kunling1,　WANG Liqi2,　ZHU Shiming2. Changes of microalbuminuria and serum high molecular weight-adiponectin in hypertensive patients with metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 78-82.
[8] ZHANG Jing-zhi1，CHENG Li-guo2，HU Xiao-qin3，JIA Hui-xin4. Effect of APS on TLR4、NF-κB expression in HUVEC-C injured by   patients blood with hypertension disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(12): 120-.
[9] MA Wei-hong1,2, BU Pei-li2, WANG Xiu-ling2, LIU Rong2, LIU Jun-ni2, LI Chang-jun2. Association of urinary albumin-to-creatinine ratio with femoral arterial stiffness in essential hypertension [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(11): 90-.
[10] . DNA damage of vascular endothelial cells caused by the serum of  patients with hypertension diseases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(7): 54-56.
[11] CHENG Wen-juan,YAN Su-hua,XING Qi-chong,WANG Qing,HU He-sheng,XUE Mei. Effects of captopril treatment on cardiac neural remodeling in rabbits with artificial myocardial infarction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(8): 792-796.
[12] LIU Yu-ying,WANG Li-qi,ZHU Shi-ming. Correlation between TGF-β1 and hypertensive target organ damage [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(5): 495-498.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd